Matches in SemOpenAlex for { <https://semopenalex.org/work/W207953313> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W207953313 endingPage "206" @default.
- W207953313 startingPage "199" @default.
- W207953313 abstract "EO9 [3-hydroxymethyl-5-aziridinyl-1-methyl-2-(H-indole-4, 7-indione)-propenol] is a novel indoloquinone structurally related to mitomycin C, a quinone anticancer drug that requires reductive bioactivation. NAD(P)H: (quinone-acceptor) oxidoreductase (quinone reductase, DT-diaphorase, EC 1.6.99.2) is an obligate 2-electron donating enzyme that can reduce a variety of quinones resulting either in bioactivation or bioprotection. Using quinone reductase (QR) preparations from rat Walker 256 mammary tumor cells and human HT29 colon carcinoma cells, we have characterized the role of this enzyme in EO9 reductive metabolism. QR activity was assayed under optimal conditions by following cytochrome c reduction at 550 nm in the presence of enzyme, quinone substrate, NADH, and bovine albumin, and confirmed by loss of EO9 absorbance at 550 nm. Both the rat and human tumor cell enzymes catalyzed reduction of the benchmark quinone menadione with a similar Km of 1.4-3.1 microM, although the Vmax was 7 to 8-fold lower for the human preparation. EO9 was readily reduced by the rat Walker QR. The mean Km was about 5-fold higher than for menadione at around 15 microM and the Vmax was 6-fold lower at around 2.5 mumol of cytochrome c reduced mg-1 of protein. EO9 was also metabolized by QR from HT29 human colon carcinoma cells but rather less efficiently than by the rat tumor enzyme. For example, the rate was 6-fold lower than that for the Walker tumor enzyme at 100 microM substrate concentration after correcting for the 7- to 8-fold difference in specific activity for the two preparations.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
- W207953313 created "2016-06-24" @default.
- W207953313 creator A5003965204 @default.
- W207953313 creator A5050924628 @default.
- W207953313 creator A5091648628 @default.
- W207953313 date "1991-07-01" @default.
- W207953313 modified "2023-09-24" @default.
- W207953313 title "The Role of NAD(P)H: Quinone Reductase (EC 1.6.99.2, DT-Diaphorase) in the Reductive Bioactivation of the Novel Indoloquinone Antitumor Agent E09" @default.
- W207953313 doi "https://doi.org/10.3727/095535491820873164" @default.
- W207953313 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1714284" @default.
- W207953313 hasPublicationYear "1991" @default.
- W207953313 type Work @default.
- W207953313 sameAs 207953313 @default.
- W207953313 citedByCount "117" @default.
- W207953313 countsByYear W2079533132012 @default.
- W207953313 countsByYear W2079533132014 @default.
- W207953313 countsByYear W2079533132015 @default.
- W207953313 countsByYear W2079533132016 @default.
- W207953313 countsByYear W2079533132017 @default.
- W207953313 countsByYear W2079533132019 @default.
- W207953313 countsByYear W2079533132020 @default.
- W207953313 countsByYear W2079533132021 @default.
- W207953313 countsByYear W2079533132022 @default.
- W207953313 crossrefType "journal-article" @default.
- W207953313 hasAuthorship W207953313A5003965204 @default.
- W207953313 hasAuthorship W207953313A5050924628 @default.
- W207953313 hasAuthorship W207953313A5091648628 @default.
- W207953313 hasConcept C134651460 @default.
- W207953313 hasConcept C181199279 @default.
- W207953313 hasConcept C185592680 @default.
- W207953313 hasConcept C2777990912 @default.
- W207953313 hasConcept C2780643102 @default.
- W207953313 hasConcept C2781095387 @default.
- W207953313 hasConcept C55493867 @default.
- W207953313 hasConcept C71240020 @default.
- W207953313 hasConcept C75520062 @default.
- W207953313 hasConceptScore W207953313C134651460 @default.
- W207953313 hasConceptScore W207953313C181199279 @default.
- W207953313 hasConceptScore W207953313C185592680 @default.
- W207953313 hasConceptScore W207953313C2777990912 @default.
- W207953313 hasConceptScore W207953313C2780643102 @default.
- W207953313 hasConceptScore W207953313C2781095387 @default.
- W207953313 hasConceptScore W207953313C55493867 @default.
- W207953313 hasConceptScore W207953313C71240020 @default.
- W207953313 hasConceptScore W207953313C75520062 @default.
- W207953313 hasIssue "7" @default.
- W207953313 hasLocation W2079533131 @default.
- W207953313 hasLocation W2079533132 @default.
- W207953313 hasOpenAccess W207953313 @default.
- W207953313 hasPrimaryLocation W2079533131 @default.
- W207953313 hasRelatedWork W1505175212 @default.
- W207953313 hasRelatedWork W1843387896 @default.
- W207953313 hasRelatedWork W1979509248 @default.
- W207953313 hasRelatedWork W1989685767 @default.
- W207953313 hasRelatedWork W1996260118 @default.
- W207953313 hasRelatedWork W1997506075 @default.
- W207953313 hasRelatedWork W2069131796 @default.
- W207953313 hasRelatedWork W207953313 @default.
- W207953313 hasRelatedWork W2091674456 @default.
- W207953313 hasRelatedWork W2094888486 @default.
- W207953313 hasVolume "3" @default.
- W207953313 isParatext "false" @default.
- W207953313 isRetracted "false" @default.
- W207953313 magId "207953313" @default.
- W207953313 workType "article" @default.